Keywords: cephalon, buy, salmedix, 160m, biotechnology, firm, says

Cephalon to buy Salmedix for $160M

Article | 23 May 2005

Print This

US biotechnology firm Cephalon says it has signed a definitive merger agreement under which it will acquire all of the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in